Private Equity

Lakestreet Capital, Palace Capital's largest shareholder, demands the removal of Chairman Steven Owen, citing excessive pay and poor governance.

Fresh off a massive 240% revenue surge, Nutex Health prepares to showcase its micro-hospital model and physician-led strategy to top global investors.

Abingworth elevates Bali Muralidhar and hires Travis Wilson, signaling a major push into clinical co-development and buyouts under Carlyle's wing.

Health Canada has approved JERAYGO, the first new hypertension drug class in 30 years, offering a lifeline to patients with hard-to-treat high blood pressure.

Patria Investments' major acquisition of CLO specialist Solis Investimentos signals a new era for private credit in Latin America's evolving market.

The eye health giant has refinanced a massive $2.8B in loans, extending debt maturity and cutting interest costs to bolster its long-term strategy.

CEO Eric Hambly will face investors at a key conference, balancing oil production strategy with the rising tide of clean technology and decarbonization.

Northann Corp. stock soars on a major retail partnership, but can its innovative 3D printing tech overcome deep financial woes and a delisting threat?

All eyes are on GH Research ahead of a crucial Jan. 5 announcement on the FDA status of its fast-acting drug for treatment-resistant depression.

Feit Electric buys the assets of embattled brand Good Earth Lighting, a strategic move to dominate retail lighting aisles after a major product recall.

A strategic partnership between Arkview Capital and BBK Capital secures NEOTech, a key electronics supplier, aiming to bolster US defense and tech manufacturing.

As DSOs and consolidation reshape Canadian dentistry, Mint Ops launches a non-broker advisory service to guide owners on growth and buy/sell decisions.

Occidental nets $9.7B from its OxyChem sale to Berkshire Hathaway, pivoting to oil and carbon capture while retaining significant environmental liabilities.

Fintech pioneer Currenc Group divests its payments hub Tranglo in a $400M deal, fueling a bold transformation into AI, Web3, and digital assets.

As robotaxis and self-driving trucks go commercial, a new group from Seeing Machines aims to solve the critical human trust and safety challenge.

Tire giant Michelin buys advanced materials firm Tex-Tech to fuel its diversification, as a new defense-focused composite entity, FMI, is spun off.

Fresh off a major drug approval, Insmed's upcoming J.P. Morgan talk is under scrutiny as investors eye pipeline updates and acquisition potential.

The organic retailer's third Wyoming store will create jobs with competitive pay and shake up the local grocery market when it opens this spring.

Nouveau Monde Graphite issues stock to pay interest to its major investor, Investissement Québec, highlighting a strategy to conserve cash for key projects.

Ironwood Pharma forecasts a massive profit jump by lowering its top drug's price, a bold move as it advances its rare disease pipeline for future growth.